BioSpace News Archive

Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the fourth quarter and full year of 2021.

Savara Inc., an orphan lung disease company, reported financial results for the fourth quarter and full year ending December 31, 2021 and provided a business update.

Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced it has formed a new leadership structure.

ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reported financial results for the three months and year ended December 31, 2021 and provided a business update.

Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, announced that the Company’s management will be participating in the 21st Annual Needham Virtual Healthcare Conference.

Scientific Industries, Inc., a life sciences tool provider, and a developer of digitally simplified bioprocessing products, announced that it will be participating in the Lytham Partners Spring 2022 Investor Conference taking place virtually on April 4-7, 2022.

Icosavax, Inc. reported financial results for the fourth quarter and full year ended December 31, 2021 and provided a corporate update.

Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX), a leader in ribosomal RNA-targeted genetic therapies for rare diseases, today announced it has expanded the ELX-02 development program to include the treatment of Alport syndrome, a rare kidney disease.

Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a novel biotechnology company focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders, is pleased to provide a business update and summary of key accomplishments since its Initial Public Offering (“IPO”) in September 2021.

SanaraMedTech Inc. announced its strategic, operational and financial results for the quarter and full year ended December 31, 2021.